Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Zhichan Tang (also known as Jiawei Zhichan Decoction) is a Traditional Chinese Medicine (TCM) formulation primarily investigated for the treatment of Parkinson's disease and its associated non-motor symptoms, such as sleep disorders. As a "Jiawei" (modified) formula, it is typically based on a core set of herbs intended to "extinguish wind" and "nourish the liver and kidney," which are traditional TCM strategies for managing tremors and neurological decline. Clinical research, including a trial registered at the Shanghai Municipal Hospital of Traditional Chinese Medicine (ChiCTR2000036490), has evaluated its efficacy in improving both motor function and non-motor complications like insomnia in patients with Parkinson's disease. The formulation is typically administered as an oral decoction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei zhichan tang.